Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
Conditions: Leukemia; Leukemia, Lymphoblastic; Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; HIV Infections; HIV Associated Lymphoma; HIV Disease; Lymphoma Intervention: Sponsors: AIDS Malignancy Consortium; Center for International Blood and Marrow Transplant Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 24, 2023 Category: Research Source Type: clinical trials
Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
Conditions: Leukemia; Leukemia, Lymphoblastic; Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; HIV Infections; HIV Associated Lymphoma; HIV Disease; Lymphoma Intervention: Sponsors: AIDS Malignancy Consortium; Center for International Blood and Marrow Transplant Research Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 24, 2023 Category: Research Source Type: clinical trials
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma
Condition: Non-hodgkin Lymphoma,B Cell Intervention: Drug: CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection Sponsors: Bioray Laboratories; Institute of Hematology ＆ Blood Diseases Hospital，Chinese Academy of Medical Sciences; Zhejiang University; Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials
